Protara CFO’s Tax‑Driven Share Sale Sparks Investor Curiosity Amid Executive Optimism
Protara Therapeutics insider trading insights: CFO’s tax‑related sale, CEO’s rebalancing, and executives’ bullish buys ahead of ASCO data.
3 minutes to read
Protara Therapeutics Inc